Evidence-Based Guidance for Strategies for Blood Transfusion with CKD and Myocardial Infarction.
作者信息
Wong Michelle M Y, Herzog Charles A
机构信息
Division of Nephrology, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Hennepin Healthcare, University of Minnesota, Minneapolis, Minnesota.
出版信息
J Am Soc Nephrol. 2025 Jun 1;36(6):1008-1010. doi: 10.1681/ASN.0000000736. Epub 2025 May 13.
Abstract
摘要
相似文献
1
Evidence-Based Guidance for Strategies for Blood Transfusion with CKD and Myocardial Infarction.慢性肾脏病与心肌梗死输血策略的循证指南
J Am Soc Nephrol. 2025 Jun 1;36(6):1008-1010. doi: 10.1681/ASN.0000000736. Epub 2025 May 13.
2
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.用于治疗慢性肾脏病贫血的持续促红细胞生成素受体激活剂（CERA）
Cochrane Database Syst Rev. 2017 Aug 7;8(8):CD009904. doi: 10.1002/14651858.CD009904.pub2.
3
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用：对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
4
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1（GLP-1）受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.
5
Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.静脉补铁与口服补铁治疗 CKD 贫血的疗效比较：一项更新的系统评价和荟萃分析。
Am J Kidney Dis. 2016 Nov;68(5):677-690. doi: 10.1053/j.ajkd.2016.04.018. Epub 2016 Jun 16.
6
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.用于非透析慢性肾脏病患者的HMG辅酶A还原酶抑制剂（他汀类药物）
Cochrane Database Syst Rev. 2023 Nov 29;11(11):CD007784. doi: 10.1002/14651858.CD007784.pub3.
7
Antioxidants for chronic kidney disease.用于慢性肾病的抗氧化剂。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008176. doi: 10.1002/14651858.CD008176.pub2.
8
Dietary interventions for adults with chronic kidney disease.针对成年慢性肾病患者的饮食干预措施。
Cochrane Database Syst Rev. 2017 Apr 23;4(4):CD011998. doi: 10.1002/14651858.CD011998.pub2.
9
Antiplatelet agents for chronic kidney disease.抗血小板药物在慢性肾脏病中的应用。
Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4.
10
Transfusion thresholds for guiding red blood cell transfusion.输血阈值指导红细胞输血。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5.
本文引用的文献
1
Restrictive or Liberal Blood Transfusion in Patients with Myocardial Infarction and CKD.心肌梗死合并慢性肾脏病患者的限制性或自由性输血
J Am Soc Nephrol. 2025 Jun 1;36(6):1116-1125. doi: 10.1681/ASN.0000000595. Epub 2025 Jan 9.
2
Impact of Chronic Kidney Disease on the Processes of Care and Long-Term Mortality of Non-ST-Segment-Elevation Myocardial Infarction: A Nationwide Cohort Study and Long-Term Follow-Up.慢性肾脏病对非 ST 段抬高型心肌梗死患者治疗过程和长期死亡率的影响：一项全国性队列研究和长期随访。
J Am Heart Assoc. 2024 Aug 20;13(16):e032671. doi: 10.1161/JAHA.123.032671. Epub 2024 Aug 9.
3
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.心肌梗死合并贫血的限制性输血或宽松性输血策略。
N Engl J Med. 2023 Dec 28;389(26):2446-2456. doi: 10.1056/NEJMoa2307983. Epub 2023 Nov 11.
4
Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts.慢性肾脏病患者血红蛋白分布的区域差异：国际肾脏病学会慢性肾脏病队列国际网络
Kidney Int Rep. 2023 Aug 12;8(10):2056-2067. doi: 10.1016/j.ekir.2023.07.032. eCollection 2023 Oct.
5
Red Blood Cell Transfusion: 2023 AABB International Guidelines.红细胞输注：2023 AABB 国际指南。
JAMA. 2023 Nov 21;330(19):1892-1902. doi: 10.1001/jama.2023.12914.
6
Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.限制与宽松输血策略对贫血急性心肌梗死患者主要心血管事件的影响：REALITY 随机临床试验。
JAMA. 2021 Feb 9;325(6):552-560. doi: 10.1001/jama.2021.0135.
7
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease.症状性冠状动脉疾病患者的自由输血与限制输血阈值。
Am Heart J. 2013 Jun;165(6):964-971.e1. doi: 10.1016/j.ahj.2013.03.001. Epub 2013 Apr 8.
8
Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study).急性心肌梗死患者的保守与自由输血策略比较（CRIT 随机试点研究）。
Am J Cardiol. 2011 Oct 15;108(8):1108-11. doi: 10.1016/j.amjcard.2011.06.014. Epub 2011 Jul 24.
9
Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study.肾功能和贫血作为冠心病及死亡率的危险因素：社区动脉粥样硬化风险（ARIC）研究
Am Heart J. 2006 Feb;151(2):492-500. doi: 10.1016/j.ahj.2005.03.055.
10
Blood transfusion in elderly patients with acute myocardial infarction.老年急性心肌梗死患者的输血治疗
N Engl J Med. 2001 Oct 25;345(17):1230-6. doi: 10.1056/NEJMoa010615.
Zotero 插件